Is Apex Omni a Good Investment?
| TVL | $35M |
| FDV | $175M |
| TVL/FDV | 0.20x |
| Risk Grade | C+ |
| Value Grade | C- |
Value Accrual: Does the Apex Omni Token Capture Value?
Apex Omni scores C- on Hindenrank's value accrual framework (42/100), indicating average value capture — some strengths offset by weaknesses in fee distribution or sustainability. Fee capture scores 15/25 — solid, capturing a reasonable share of protocol revenue. Token distribution is rated 8/25 (significantly concentrated among insiders or early investors), and emission sustainability sits at 9/25. The competitive moat dimension scores 10/25.
Protocol Health: Is Apex Omni Still Growing?
Apex Omni's vitality risk score is 5/10 on Hindenrank's rubric (lower is healthier). This suggests moderate health — Apex Omni is maintaining activity but may be showing signs of plateauing growth or reduced developer engagement. The protocol is functional but may not be accelerating.
Risk-Adjusted View: Is the Upside Worth the Risk?
Risk-Adjusted Position
NeutralApex Omni sits in the Neutral zone — average on both risk (C+) and value (C-). There is no strong reason to overweight or avoid the token at current levels. Monitor for catalysts that could shift the balance in either direction.
Risk Context
Apex Omni carries a risk grade of C+ (36/100), classified as elevated risk — multiple novel mechanisms and notable interaction risks. While no critical-severity interactions were identified, 1 high-severity interaction warrant attention. The primary risk factor is: Multi-chain perpetual trading across 5+ chains introduces cross-chain composability risk and potential for oracle inconsistencies between chains.
Read our full safety analysis →Where Apex Omni Sits Among Derivatives Peers
On risk, Apex Omni ranks #17 of 56 Derivatives protocols (above-median). That's 4 points safer than the sector average of 40/100.
The closest peer by risk profile is Injective (grade C+, 36/100). See the side-by-side comparison to weigh their tradeoffs.
Should you buy Apex Omni?
Apex Omni scores C- on Hindenrank's value accrual framework, placing it among the average Derivatives protocols. Fee capture scores 15/25 — solid, capturing a reasonable share of protocol revenue. Token distribution is significantly concentrated among insiders or early investors, and emission sustainability sits at 9/25. On the risk side, Apex Omni carries a C+ grade (36/100), which is elevated risk — multiple novel mechanisms and notable interaction risks. The combined risk-value position places Apex Omni in the Neutral quadrant.
Apex Omni investment outlook for 2026
With $35M in total value locked and FDV of $175M, giving a TVL/FDV ratio of 0.20, Apex Omni's fundamentals do not strongly support the current valuation from a usage perspective. The competitive moat dimension scores 10/25, suggesting limited moat, leaving the protocol vulnerable to competitive pressure.Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.
This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology
Weekly Commentary
ProWeek of March 3, 2026
Apex Omni's B- risk grade reflects solid operational fundamentals for a derivatives venue, but the C- value score tells the real story — token holders aren't capturing meaningful upside from platform activity. At $38M TVL, this is a well-built protocol that hasn't found its growth catalyst, squarely earning its "Safe but Stale" label. You're unlikely to lose money here, but you're equally unlikely to make any.
Exploring options?
Compare Derivatives Alternatives →Related Derivatives Investment Analyses
Related Derivatives Safety Analyses
Get risk alerts before it's too late
Weekly grade changes, downgrade alerts, and new protocol risk findings. Free.